Nadig Nandita R, Brinton Daniel L, Simpson Kit N, Goodwin Andrew J, Simpson Annie N, Ford Dee W
Department of Medicine, Division of Pulmonary, Critical Care Medicine and Sleep, Northwestern University Feinberg School of Medicine, Chicago, IL.
Department of Healthcare Leadership and Management, Medical University of South Carolina, Charleston, SC.
Crit Care Explor. 2022 Mar 1;4(3):e0642. doi: 10.1097/CCE.0000000000000642. eCollection 2022 Mar.
Approximately one in 30 patients with acute respiratory failure (ARF) undergoes an inter-ICU transfer. Our objectives are to describe inter-ICU transfer patterns and evaluate the impact of timing of transfer on patient-centered outcomes.
Retrospective, quasi-experimental study.
We used the Healthcare Cost and Utilization Project State Inpatient Databases in five states (Florida, Maryland, Mississippi, New York, and Washington) during 2015-2017.
We selected patients with , 9th and 10th Revision codes of respiratory failure and mechanical ventilation who underwent an inter-ICU transfer ( = 6,718), grouping as early (≤ 2 d) and later transfers (3+ d). To control for potential selection bias, we propensity score matched patients (1:1) to model propensity for early transfer using a priori defined patient demographic, clinical, and hospital variables.
Inhospital mortality, hospital length of stay (HLOS), and cumulative charges related to inter-ICU transfer.
Six-thousand seven-hundred eighteen patients with ARF underwent inter-ICU transfer, 68% of whom ( = 4,552) were transferred early (≤ 2 d). Propensity score matching yielded 3,774 well-matched patients for this study. Unadjusted outcomes were all superior in the early versus later transfer cohort: inhospital mortality (24.4% vs 36.1%; < 0.0001), length of stay (8 vs 22 d; < 0.0001), and cumulative charges ($118,686 vs $308,977; < 0.0001). Through doubly robust multivariable modeling with random effects at the state level, we found patients who were transferred early had a 55.8% reduction in risk of inhospital mortality than those whose transfer was later (relative risk, 0.442; 95% CI, 0.403-0.497). Additionally, the early transfer cohort had lower HLOS (20.7 fewer days [13.0 vs 33.7; < 0.0001]), and lower cumulative charges ($66,201 less [$192,182 vs $258,383; < 0.0001]).
Our study is the first to use a large, multistate sample to evaluate the practice of inter-ICU transfers in ARF and also define early and later transfers. Our findings of favorable outcomes with early transfer are vital in designing future prospective studies evaluating evidence-based transfer procedures and policies.
每30例急性呼吸衰竭(ARF)患者中约有1例接受重症监护病房(ICU)间转运。我们的目标是描述ICU间转运模式,并评估转运时机对以患者为中心的结局的影响。
回顾性、准实验性研究。
我们使用了2015 - 2017年期间五个州(佛罗里达州、马里兰州、密西西比州、纽约州和华盛顿州)的医疗成本和利用项目州住院数据库。
我们选择了具有呼吸衰竭和机械通气的第9和第10版编码且接受了ICU间转运的患者(n = 6718),分为早期(≤2天)和晚期转运(3天及以后)。为控制潜在的选择偏倚,我们使用预先定义的患者人口统计学、临床和医院变量,通过倾向得分匹配患者(1:1)来模拟早期转运的倾向。
住院死亡率、住院时间(HLOS)以及与ICU间转运相关的累计费用。
6718例ARF患者接受了ICU间转运,其中68%(n = 4552)为早期转运(≤2天)。倾向得分匹配为本研究产生了3774例匹配良好的患者。早期转运队列与晚期转运队列相比,未调整的结局均更优:住院死亡率(24.4%对36.1%;P < 0.0001)、住院时间(8天对22天;P < 0.0001)以及累计费用(118,686美元对308,977美元;P < 0.0001)。通过在州层面进行具有随机效应的双重稳健多变量建模,我们发现早期转运的患者住院死亡风险比晚期转运的患者降低了55.8%(相对风险,0.442;95%可信区间,0.403 - 0.497)。此外,早期转运队列的HLOS更低(少20.7天[13.0天对33.7天;P < 0.0001]),累计费用更低(少66,201美元[192,182美元对258,383美元;P < 0.0001])。
我们的研究首次使用大型多州样本评估ARF患者ICU间转运的实践,并定义了早期和晚期转运。我们关于早期转运有良好结局的发现对于设计未来评估基于证据的转运程序和政策的前瞻性研究至关重要。